Home » Research Archive » 2008 » View Cart | My Account   

Currencies

Ca2+-dependent Calmodulin Binding to FcRn Affects Immunoglobulin G Transport in the Transcytotic Pathway*

Dickinson*,Bonny L., Steven M. Claypool, June A. D'Angelo*,, Martha L. Aiken*,, Nanda Venu, Elizabeth H. Yen, Jessica S. Wagner,||, Jason A. Borawski, Amy T. Pierce*,, Robert Hershberg¶, Richard S. Blumberg,||, and Wayne I. Lencer||, 2008, Mol. Biol. Cell: 19:414-423.

*The Research Institute for Children, Children's Hospital, Department of Pediatrics, New Orleans, LA 70118;  Department of Microbiology, Immunology, and Parasitology, Louisiana State University Health Science Center, New Orleans, LA 70112;  Division of Gastroenterology, Brigham and Women's Hospital and the Department of Medicine, Harvard Medical School, Boston, MA 02115;  Gastrointestinal Cell Biology, Division of Pediatric Gastroenterology and Nutrition, Children's Hospital and the Department of Pediatrics, Harvard Medical School, Boston, MA 02115; ¶Department of Medicine and Medical Genetics, University of Washington School of Medicine, Seattle, WA 98112; and ||Harvard Digestive Diseases Center, Boston, MA 02115

Abstract

The Fc receptor FcRn transports immunoglobulin G (IgG) so as to avoid lysosomal degradation and to carry it bidirectionally across epithelial barriers to affect mucosal immunity. Here, we identify a calmodulin-binding site within the FcRn cytoplasmic tail that affects FcRn trafficking. Calmodulin binding to the FcRn tail is direct, calcium-dependent, reversible, and specific to residues comprising a putative short amphipathic -helix immediately adjacent to the membrane. FcRn mutants with single residue substitutions in this motif, or FcRn mutants lacking the cytoplasmic tail completely, exhibit a shorter half-life and attenuated transcytosis. Chemical inhibitors of calmodulin phenocopy the mutant FcRn defect in transcytosis. These results suggest a novel mechanism for regulation of IgG transport by calmodulin-dependent sorting of FcRn and its cargo away from a degradative pathway and into a bidirectional transcytotic route.

*Note: Normal Chicken IgY antibodies used in this publication were produced by Gallus Immunotech Inc. Please visit our Normal Chicken IgY page or see our Product Specifications for this product

 
Print This Page